Key Proteo, Inc.

Key Proteo is democratizing the early detection of rare but treatable genetic disorders through novel and accessible proteomic analysis. As a pioneering proteomics company, Key Proteo is initially focused on the early detection of treatable rare genetic disorders in newborns, with the goal of expand... Read more